Medical University of South Carolina

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Medical University of South Carolina sits in the top decile of US sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count).

755 total trials 142 currently recruiting 520 completed early-phase tilt top decile by trial count

Medical University of South Carolina: 755 sponsored US clinical trials, 142 recruiting.

Medical University of South Carolina sponsors 755 registered US clinical trials on ClinicalTrials.gov, 142 of them currently recruiting, and 520 completed. 66 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 15 trials.

Top-decile sponsor footprint

Medical University of South Carolina ranks in the top decile of sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 64/100

520 of 580 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

755 total, page 6 of 16

TERMINATED NA

Feasibility of Music Therapy for Spontaneous Breathing Trials

NCT05008328

COMPLETED NA

PTSD Treatment and Emotion Regulation Skills Training for Veterans With Military Sexual Trauma (PE+ER)

NCT04792775

COMPLETED Early Phase 1

NAC +taVNS in IDM Who Are Poor Oral Feeders

NCT04632069

COMPLETED NA

Impact of More Frequent PT Services

NCT04778475

COMPLETED NA

Cognitive Interference Task on Alcohol Craving and Consumption

NCT04924283

COMPLETED NA

ESCAPE Kits for Elopement Prevention in Children With Autism

NCT07225907

COMPLETED NA

Goal2QuitVaping for Nicotine Vaping Cessation Among Adolescents

NCT04951193

TERMINATED Phase 4

Mothers' Own Milk Optimization for Preterm Infants Project (MoMO PIP) Pilot Study

NCT04629534

COMPLETED NA

Using Yogic Breathing to Reduce Stress in Anesthesia Personnel As Measured by Hair Cortisol

NCT04858815

COMPLETED NA

Plasticity Using Stimulation and Habit: A Pilot Open-label rTMS Study for MCI

NCT04503096

COMPLETED

Multicenter Study Into Individualized Scanning for Coronary Artery Disease

NCT04837846

COMPLETED NA

A Trial of Adding Lung Protective Strategies to Existing Enhanced Recovery After Surgery (ERAS) Protocols and Its Effects on Improving Post-Operative Lung Function

NCT04411186

COMPLETED NA

Exercise-primed Upper Extremity Motor Practice in Chronic Stroke

NCT04259424

COMPLETED NA

Physiological Changes Induced Through MEP Conditioning in People With SCI

NCT04286191

COMPLETED NA

Examining the Effects of Art Therapy in Reducing Burnout in Healthcare Providers

NCT04738448

COMPLETED Phase 1

STARS (Smoking Treatment And Remote Sampling) Study

NCT04525755

COMPLETED NA

Transradial-Band Pilot Study

NCT04709341

COMPLETED Phase 1

A Pilot Trial to Determine the Effective N-acetylcysteine Dose for Opioid Reduction for Spine Surgery.

NCT04562597

COMPLETED NA

Impact of the Be Well Care Well Program on Early Care Education Teachers

NCT05310201

COMPLETED

Direct Measurement of Motor Cortical Responses to tDCS

NCT04759898

COMPLETED Phase 2

Neurocircuit Strategy to Decrease Cocaine Cue Reactivity

NCT04155632

COMPLETED Phase 2

Ketamine for the Treatment of Opioid Use Disorder and Depression

NCT04177706

COMPLETED

COVID Breath Test - Ancon

NCT04760639

COMPLETED NA

Pilot Randomized Controlled Trial (RCT): Remote SBIRT Vs. In-Person SBIRT

NCT04630249

COMPLETED NA

The Psychosocial Outcomes in Caregivers of Children With Food Allergy

NCT04512924

COMPLETED NA

The HEART Study (Healthy Eating and Recovery Together)

NCT04552587

COMPLETED NA

Contingency Management to Promote Smoking Abstinence in Cancer Patients

NCT04605458

COMPLETED Phase 2

NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis

NCT04638673

COMPLETED Phase 1

Weekly Isotretinoin Therapy Study

NCT04594759

COMPLETED NA

Concomitant Sensory Stimulation During Therapy to Enhance Hand Functional Recovery Post Stroke

NCT04569123

COMPLETED NA

Use of Novel Sinusonic Device for Prevention of Community Acquired Upper Respiratory Infection (URI)

NCT04468204

COMPLETED

Thin EBUS Pilot Study

NCT04745962

COMPLETED NA

CCCR Lupus Patient Navigator Program

NCT04461158

COMPLETED Phase 1

DSAP Treatment Comparison: 2% Lovastatin/ 2% Cholesterol vs 2% Lovastatin Alone

NCT04359823

COMPLETED Phase 2

Speech Entrainment for Aphasia Recovery

NCT04364854

COMPLETED NA

Cognitive Behavioral Therapy for Insomnia with RTMS

NCT04258618

COMPLETED NA

IQOS (Non-Cigarette Tobacco Product) Pilot Study

NCT04357379

COMPLETED NA

QL vs LP Blocks for Analgesia Following THA

NCT04402437

COMPLETED Phase 3

Efficacy of SLN Block for Chronic Cough

NCT04421092

COMPLETED NA

SMYLS: A Self-management Program for Youth Living With Sickle Cell Disease

NCT04289311

COMPLETED NA

Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) 2.0

NCT03831100

COMPLETED NA

Goal2Quit + NRT Sampling

NCT03837379

COMPLETED NA

Salt-Based E-cigarette

NCT04238832

COMPLETED Phase 1

Clinical Trial Intelligent Biometrics for PTSD - Clinical Trial

NCT04471207

TERMINATED NA

Initial Intervention Efficacy for an Online PTSD Intervention for Pregnant Women

NCT04264520

COMPLETED NA

Navigation vs Usual Care for Timely Adjuvant Therapy for Patients With Locally Advanced HNSCC

NCT04030130

COMPLETED NA

SinuSonic for ETD and Facial Pain: Acoustic Vibration + Oscillating Expiratory Pressure

NCT04404036

COMPLETED Phase 2

Addition of Opaganib to Androgen Antagonists in Patients With mCRPC

NCT04207255

COMPLETED NA

Noninvasive VNS to Facilitate Excitability in Motor Cortex

NCT04130646

COMPLETED Early Phase 1

High Volume Caudal Study

NCT04263064

← Previous Page 6 of 16 Next →

Phase Distribution

PhaseTrial count
Phase 1 104
Phase 2 124
Phase 3 23
Phase 4 43

What is open in the Medical University of South Carolina pipeline

142 recruiting of 755 indexed (19% open); 520 completed (69%).

Phase mix: 66 late (III/IV) vs 228 early (I/II) (early-phase heavy).

Top condition: Stroke (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Medical University of South Carolina: open-pipeline peers nationwide

Peers matched on 755 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 14%16%18%20%22% Total trials Recruiting share Medical University of South CarolinaUniversity of California, San DiegoThe University of Texas Health Science Center, HoustonDana-Farber Cancer InstituteUniversity of MiamiSpaulding Rehabilitation HospitalIpsenEyePoint PharmaceuticalsHebrew SeniorLife
Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 755 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this Medical University of South Carolina page

755 registered trials is a research-attention snapshot, not an endorsement of Medical University of South Carolina or any single study.

  • 142 of Medical University of South Carolina's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Stroke is the condition Medical University of South Carolina studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Medical University of South Carolina pipeline card: 755 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.